These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2543625)

  • 1. Use of inhibitory (anti-catalytic) antibodies to study extracellular proteolysis.
    Birkedal-Hansen H; Birkedal-Hansen B; Windsor LJ; Lin HY; Taylor RE; Moore WG
    Immunol Invest; 1989; 18(1-4):211-24. PubMed ID: 2543625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase.
    Birkedal-Hansen H; Lin HY; Birkedal-Hansen B; Windsor LJ; Pierson MC
    Matrix Suppl; 1992; 1():368-74. PubMed ID: 1480062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.
    HE CS; Wilhelm SM; Pentland AP; Marmer BL; Grant GA; Eisen AZ; Goldberg GI
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2632-6. PubMed ID: 2468156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade.
    Thomson BM; Atkinson SJ; McGarrity AM; Hembry RM; Reynolds JJ; Meikle MC
    Biochim Biophys Acta; 1989 Nov; 1014(2):125-32. PubMed ID: 2554972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteases induce secretion of collagenase and plasminogen activator by fibroblasts.
    Werb Z; Aggeler J
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1839-43. PubMed ID: 205872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of tPA-dependent provisional extracellular fibrin matrix degradation by human recombinant soluble melanotransferrin.
    Bertrand Y; Demeule M; Rivard GE; Béliveau R
    Biochim Biophys Acta; 2006 Oct; 1763(10):1024-30. PubMed ID: 16979249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody interferes with fibrin binding of t-PA.
    Matsuo O; Okada K; Fukao H; Tanaka N; Ueshima S
    Thromb Res; 1988 Sep; 51(5):485-94. PubMed ID: 2459803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.
    Keski-Oja J; Lohi J; Tuuttila A; Tryggvason K; Vartio T
    Exp Cell Res; 1992 Oct; 202(2):471-6. PubMed ID: 1397099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nine residue plasminogen-binding motif of the pneumococcal enolase is the major cofactor of plasmin-mediated degradation of extracellular matrix, dissolution of fibrin and transmigration.
    Bergmann S; Rohde M; Preissner KT; Hammerschmidt S
    Thromb Haemost; 2005 Aug; 94(2):304-11. PubMed ID: 16113819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic enzymes in cancer invasion and metastasis.
    Goldfarb RH; Liotta LA
    Semin Thromb Hemost; 1986 Oct; 12(4):294-307. PubMed ID: 3024322
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
    Lijnen HR; Dewerchin M; De Cock F; Collen D
    Thromb Res; 1990 Feb; 57(3):333-42. PubMed ID: 2107593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration.
    Berman M; Leary R; Gage J
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1204-21. PubMed ID: 6252112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices.
    Berton A; Lorimier S; Emonard H; Laurent-Maquin D; Hornebeck W; Bellon G
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):173-80. PubMed ID: 10860866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin.
    Festuccia C; Guerra F; D'Ascenzo S; Giunciuglio D; Albini A; Bologna M
    Int J Cancer; 1998 Jan; 75(3):418-31. PubMed ID: 9455804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of anti-plasmin antibodies in the antiphospholipid syndrome that inhibit degradation of fibrin.
    Yang CD; Hwang KK; Yan W; Gallagher K; FitzGerald J; Grossman JM; Hahn BH; Chen PP
    J Immunol; 2004 May; 172(9):5765-73. PubMed ID: 15100323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of plasminogen by T-PA-PAI-1 complex in the absence of fibrin.
    Takada Y; Takada A
    Thromb Res; 1991 Jul; 63(1):169-77. PubMed ID: 1835180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.